Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Conditions
Soft Tissue Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Arizona, Phoenix, Arizona, United States
USC Norris comprehensive cancer center, Los Angeles, California, United States
Stanford University Medical Centre, Palo Alto, California, United States
UCSF, San Francisco, California, United States
UCLA, Santa Monica, California, United States
University of Colorado Cancer Center/ CU Anschutz Medical Campus, Aurora, Colorado, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
University of Miami/ Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Northwestern, Chicago, Illinois, United States
Indiana University, Indianapolis, Indiana, United States
University of Iowa, Iowa City, Iowa, United States
Mass General Brigham Cancer Center, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
NYU Langone Health, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Ohio State University Wexner Medical Center/ The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
UPenn (Abramson Cancer Center, Pennsylvania Hospital), Philadelphia, Pennsylvania, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, United States
UHN - Princess Margaret Cancer Center (Ontario), Toronto, Ontario, Canada
McGill University Health Centre (Quebec), Montreal, Quebec, Canada
Chang Gung Medical Foundation Kaohsiung, Kaohsiung City, Niaosong District, Taiwan
National Taiwan University Hospital, Taipei, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taipei, Taiwan
Study leads
John S Bomalaski
Study Director
Polaris Group
No study contact email or phone is listed for this trial.